These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28157165)

  • 21. Personalized Medicine: Cell and Gene Therapy Based on Patient-Specific iPSC-Derived Retinal Pigment Epithelium Cells.
    Li Y; Chan L; Nguyen HV; Tsang SH
    Adv Exp Med Biol; 2016; 854():549-55. PubMed ID: 26427458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
    Menon S; Shailendra S; Renda A; Longaker M; Quarto N
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
    Das AK; Pal R
    J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stem cell treatment of degenerative eye disease.
    Mead B; Berry M; Logan A; Scott RA; Leadbeater W; Scheven BA
    Stem Cell Res; 2015 May; 14(3):243-57. PubMed ID: 25752437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia increases the yield of photoreceptors differentiating from mouse embryonic stem cells and improves the modeling of retinogenesis in vitro.
    Garita-Hernández M; Diaz-Corrales F; Lukovic D; González-Guede I; Diez-Lloret A; Valdés-Sánchez ML; Massalini S; Erceg S; Bhattacharya SS
    Stem Cells; 2013 May; 31(5):966-78. PubMed ID: 23362204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases.
    Wiley LA; Burnight ER; Songstad AE; Drack AV; Mullins RF; Stone EM; Tucker BA
    Prog Retin Eye Res; 2015 Jan; 44():15-35. PubMed ID: 25448922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation.
    Lewandowski J; Kurpisz M
    Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):349-70. PubMed ID: 26939778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reprint of "iPSCs, aging and age-related diseases".
    Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
    N Biotechnol; 2015 Jan; 32(1):169-79. PubMed ID: 25479728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mathematical Models of Pluripotent Stem Cells: At the Dawn of Predictive Regenerative Medicine.
    Pir P; Le Novère N
    Methods Mol Biol; 2016; 1386():331-50. PubMed ID: 26677190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of biomaterials to advance induced pluripotent stem cell research and therapy.
    Tong Z; Solanki A; Hamilos A; Levy O; Wen K; Yin X; Karp JM
    EMBO J; 2015 Apr; 34(8):987-1008. PubMed ID: 25766254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of Retinal Cells from Confluent Human iPS Cells.
    Reichman S; Goureau O
    Methods Mol Biol; 2016; 1357():339-51. PubMed ID: 25417064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reprogramming of Adult Retinal Müller Glial Cells into Human-Induced Pluripotent Stem Cells as an Efficient Source of Retinal Cells.
    Slembrouck-Brec A; Rodrigues A; Rabesandratana O; Gagliardi G; Nanteau C; Fouquet S; Thuret G; Reichman S; Orieux G; Goureau O
    Stem Cells Int; 2019; 2019():7858796. PubMed ID: 31396286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell therapy in retinal diseases.
    Voisin A; Pénaguin A; Gaillard A; Leveziel N
    Neural Regen Res; 2023 Jul; 18(7):1478-1485. PubMed ID: 36571345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regenerative Medicine: Solution in Sight.
    Wang Q; Stern JH; Temple S
    Adv Exp Med Biol; 2016; 854():543-8. PubMed ID: 26427457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential and Challenges of Induced Pluripotent Stem Cells in Liver Diseases Treatment.
    Yu Y; Wang X; Nyberg SL
    J Clin Med; 2014 Sep; 3(3):997-1017. PubMed ID: 26237490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of retinal cells from pluripotent stem cells.
    Jin ZB; Takahashi M
    Prog Brain Res; 2012; 201():171-81. PubMed ID: 23186714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.